News Breaks |
|
|
| January 2, 2013 |
| 06:19 EDT |  | AMRN, XLE | Stocks with implied volatility movement; AMRN XLE Stocks with implied volatility movement; Amarin (AMRN), Energy Select Sector SPDR (XLE) according to iVolatility. |
|
|
News For AMRN;XLE From The Last 14 Days Check below for free stories on AMRN;XLE the last two weeks. |
|
|
| May 24, 2013 |
| 08:46 EDT |  | XLE | Energy Select Sector SPDR: Pivot points The following are the pivot points for XLE. Pivot High: $82.860, Pivot Low: $81.520. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low. |
|
| May 23, 2013 |
| 11:55 EDT |  | AMRN | Options with decreasing implied volatility: AEGR PXP AMRN DSX ACT
Subscribe for More Information |
|
| 08:46 EDT |  | XLE | Energy Select Sector SPDR: Pivot points
Subscribe for More Information |
|
| May 22, 2013 |
| 11:56 EDT |  | AMRN | Options with decreasing implied volatility: WCRX NTI PXP AMRN BBY
|
|
| 08:46 EDT |  | XLE | Energy Select Sector SPDR: Pivot points
Subscribe for More Information |
|
| 06:07 EDT |  | AMRN | Amarin announces patent allowance related to combination of Vascepa, Statin Amarin announced that the United States Patent and Trademark Office has published notification of a Notice of Allowance for Amarin's U.S. Patent Application Serial Number 13/417,899 titled "Pharmaceutical Compositions Comprising EPA and a Cardiovascular Agent and Methods of Using the Same." This application includes claims intended to protect the Vascepa indication approved by the FDA based on Amarin's MARINE clinical trial results specifically those results seen in patients on statin therapy. The claims in this allowed application cover a method to reduce triglycerides in subjects having a triglyceride level of 500mg/dl to 1500mg/dl who are also receiving statin therapy using an amount of Vascepa effective to reduce triglycerides without substantially increasing low density lipoprotein cholesterol. |
|
| May 21, 2013 |
| 11:41 EDT |  | AMRN | Options with decreasing implied volatility: SGMO WCRX NTI TSLA AMRN
|
|
| 08:46 EDT |  | XLE | Energy Select Sector SPDR: Pivot points
Subscribe for More Information |
|
| May 20, 2013 |
| 08:46 EDT |  | XLE | Energy Select Sector SPDR: Pivot points
Subscribe for More Information |
|
| May 17, 2013 |
| 14:12 EDT |  | AMRN | Amarin shares slip after FDA updates Orange Book
Subscribe for More Information |
| |
| 08:46 EDT |  | XLE | Energy Select Sector SPDR: Pivot points
Subscribe for More Information |
|
| May 16, 2013 |
| 08:46 EDT |  | XLE | Energy Select Sector SPDR: Pivot points
Subscribe for More Information |
|
| May 15, 2013 |
| 11:04 EDT |  | AMRN | Amarin management to meet with Lazard Capital Meeting to be held in the Mid-Atlantic area on May 16 hosted by Lazard Capital. |
|
| 08:46 EDT |  | XLE | Energy Select Sector SPDR: Pivot points The following are the pivot points for XLE. Pivot High: $81.965, Pivot Low: $80.840. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.
|
|
| May 14, 2013 |
| 08:46 EDT |  | XLE | Energy Select Sector SPDR: Pivot points
Subscribe for More Information |
|
| May 13, 2013 |
| 12:52 EDT |  | AMRN | Amarin strength attributed to MassHealth drug list addition
Subscribe for More Information |
|
| 08:47 EDT |  | XLE | Energy Select Sector SPDR: Pivot points
Subscribe for More Information |
|
|
|
|
|